{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:49:33Z","timestamp":1783745373478,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In intensive care units (ICUs), infections by multidrug-resistant (MDR) microorganisms should be monitored to prevent healthcare-associated infections (HAIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From 2018 to 2020, we investigated all medical records of patients admitted to the ICU of a public university hospital. All patients colonized\/infected by MDR microorganisms and submitted to active surveillance cultures (ASCs) were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>Male patients prevailed, and 9.5% were positive for MDR bacteria. In-hospital deaths were statistically significant (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05) for older patients, patients with orotracheal tube use during previous and current hospitalization, and patients with high blood pressure, cardiac and pulmonary diseases, and chronic kidney disease. Carbapenem resistant Enterobacteriaceae was the most frequently resistance profile, followed by extended-spectrum beta-lactamase. The diagnosis or evolution of HAIs was statistically significant (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001) for patients treated with meropenem and vancomycin, and in-hospital deaths occurred in 29.5% of patients using polypeptides while the use of macrolides reduced the odds for mortality. The BRADEN Scale demonstrated that 50% of the patients were at high risk of dying.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients hospitalized in the ICU, colonized or infected by MDR bacteria, using invasive medical devices, and with underlying medical conditions presented increased mortality rates. The prescription of meropenem and vancomycin should be carefully monitored once patients using these antimicrobials already have or develop an HAI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1297350","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:07:31Z","timestamp":1704694051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between multidrug-resistant bacteria and outcomes in intensive care unit patients: a non-interventional study"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessandro Pacheco Silveira","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Pacheco Silveira Martins","family":"da Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uener Ribeiro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Augusto","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Marilea Meireiles","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Debortoli","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Guatimosim","family":"Vidigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Dutra","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Gon\u00e7alves","family":"dos Santos-Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"ref1","year":"2019"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"000194","DOI":"10.1099\/acmi.0.000194","article-title":"Disinfection of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium and Acinetobacter baumannii using Klaran WD array system","volume":"3","author":"Mariita","year":"2021","journal-title":"Access Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13756-019-0590-7","article-title":"Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review","volume":"8","author":"Zhen","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"000613.v6","DOI":"10.1099\/acmi.0.000613.v6","article-title":"Monitoring the battleground: exploring antimicrobial resistance and virulence factors in wound bacterial isolates","volume":"5","author":"Awuor","year":"2023","journal-title":"Access Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11900","DOI":"10.1038\/s41598-020-68233-6","article-title":"Direct identification of bacterial and human proteins from infected wounds in living 3D skin models","volume":"10","author":"Havlikova","year":"2020","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1017\/ice.2019.322","article-title":"Comparison of surveillance and clinical cultures to measure the impact of infection control interventions on the incidence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in the hospital","volume":"41","author":"Surbhi-Leekha","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"79867","DOI":"10.34117\/bjdv8n12-204","article-title":"Surveillance of multi-resistant microorganisms and epidemiological investigation of intensive care unit patients","volume":"8","author":"Martins","year":"2022","journal-title":"Bras J Dev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5935\/0103-507X.20160052","article-title":"O que todo intensivista deveria saber sobre os sistemas de escore progn\u00f3stico e mortalidade ajustada ao risco","volume":"28","author":"Keegan","year":"2016","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHEII: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00003246-197403000-00001","article-title":"Therapeutic intervention scoring system: a method for quantitative comparison of patient care","volume":"2","author":"Cullen","year":"1974","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00003246-198301000-00001","article-title":"Therapeutic intervention scoring system: update 1983","volume":"11","author":"Keene","year":"1983","journal-title":"Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"888.e11","DOI":"10.1016\/j.cmi.2016.07.012","article-title":"Impact of a targeted isolation strategy at intensive-care-unit admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before-after study","volume":"22","author":"Ledoux","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref15","year":"2020"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"103227","DOI":"10.1016\/j.iccn.2022.103227","article-title":"Healthcare-associated infections in adult intensive care unit patients: changes in epidemiology, diagnosis, prevention and contributions of new technologies","volume":"70","author":"Blot","year":"2022","journal-title":"Intens Crit Care Nurs"},{"key":"ref17","article-title":"Preventing health care\u2013associated infections","volume-title":"Patient Safety and Quality: An Evidence-Based Handbook for Nurses","author":"Collins","year":""},{"key":"ref18","author":"Damaceno","year":"2014"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/S0103-21002013000200013","article-title":"Infec\u00e7\u00e3o ou coloniza\u00e7\u00e3o por micro-organismos resistentes: identifica\u00e7\u00e3o de preditores","volume":"26","author":"Moraes","year":"2013","journal-title":"Acta Paul Enferm"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/ofid\/ofz110","article-title":"External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals","volume":"6","author":"Kadri","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/tropicalmed4010022","article-title":"One health\u2014its importance in helping to better control antimicrobial resistance","volume":"4","author":"Collignon","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"ref22","year":"2019"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/0034-7167-2019-0413","article-title":"A Escala de Braden na avalia\u00e7\u00e3o do risco para les\u00e3o por press\u00e3o","volume":"73","author":"Jansen","year":"2020","journal-title":"Rev Bras Enferm"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/IDR.S386311","article-title":"Tracking epidemiological characteristics and risk factors of multi-drug resistant Bacteria in intensive care units","volume":"16","author":"Wu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref26","unstructured":"2019"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Duin","year":"2017","journal-title":"Virulence"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e187665","DOI":"10.1001\/jamanetworkopen.2018.7665","article-title":"Risk assessment after a severe hospital-acquired infection associated with Carbapenemase-producing Pseudomonas aeruginosa","volume":"2","author":"Hopman","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1297350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:07:35Z","timestamp":1704694055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1297350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2023.1297350"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1297350","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1297350"}}